Dr Suleman J Bangash, DO | |
1750 N Randall Rd, Suite 120, Elgin, IL 60123-7900 | |
(847) 608-6647 | |
(847) 608-6674 |
Full Name | Dr Suleman J Bangash |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 24 Years |
Location | 1750 N Randall Rd, Elgin, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942302864 | NPI | - | NPPES |
216665 | Other | IL | MEDICARE GROUP PTAN |
K50412 | Other | IL | MEDICARE INDIVIDUAL PTAN |
160582 | Other | FL | BLUE CROSS BLUE SHIELD |
F400179686 | Other | IL | MEDICARE INDIVIDUAL PTAN |
K51558 | Other | IL | MEDICARE INDIVIDUAL PTAN |
216361 | Other | IL | MEDICARE GROUP PTAN |
F100179678 | Other | IL | MEDICARE GROUP PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 036-116375 (Illinois) | Primary |
207N00000X | Dermatology | OS9518 (Florida) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ab Dermatology Llc | 4789906322 | 8 |
Suleman J Bangash Dosc | 8729165006 | 11 |
News Archive
Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain.
Pfizer Inc. announced today that, in the interest of patient safety, it is voluntarily withdrawing Thelin® (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in regions where it is approved (the European Union, Canada and Australia). In addition, Pfizer is discontinuing clinical studies of Thelin worldwide.
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
A study by scientists at the University of California, San Diego and UC Irvine has identified an enzyme called a proteasome phosphatase that appears to regulate removal of damaged proteins from a cell. The understanding of how this process works could have important implications for numerous diseases, including cancer and Parkinson's disease.
› Verified 9 days ago
Entity Name | Suleman J Bangash Dosc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841469830 PECOS PAC ID: 8729165006 Enrollment ID: O20080410000668 |
News Archive
Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain.
Pfizer Inc. announced today that, in the interest of patient safety, it is voluntarily withdrawing Thelin® (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in regions where it is approved (the European Union, Canada and Australia). In addition, Pfizer is discontinuing clinical studies of Thelin worldwide.
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
A study by scientists at the University of California, San Diego and UC Irvine has identified an enzyme called a proteasome phosphatase that appears to regulate removal of damaged proteins from a cell. The understanding of how this process works could have important implications for numerous diseases, including cancer and Parkinson's disease.
› Verified 9 days ago
Entity Name | Ab Dermatology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285043646 PECOS PAC ID: 4789906322 Enrollment ID: O20141209002201 |
News Archive
Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain.
Pfizer Inc. announced today that, in the interest of patient safety, it is voluntarily withdrawing Thelin® (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in regions where it is approved (the European Union, Canada and Australia). In addition, Pfizer is discontinuing clinical studies of Thelin worldwide.
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
A study by scientists at the University of California, San Diego and UC Irvine has identified an enzyme called a proteasome phosphatase that appears to regulate removal of damaged proteins from a cell. The understanding of how this process works could have important implications for numerous diseases, including cancer and Parkinson's disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Suleman J Bangash, DO 1750 N Randall Rd, Suite 120, Elgin, IL 60123-7900 Ph: (847) 608-6647 | Dr Suleman J Bangash, DO 1750 N Randall Rd, Suite 120, Elgin, IL 60123-7900 Ph: (847) 608-6647 |
News Archive
Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain.
Pfizer Inc. announced today that, in the interest of patient safety, it is voluntarily withdrawing Thelin® (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in regions where it is approved (the European Union, Canada and Australia). In addition, Pfizer is discontinuing clinical studies of Thelin worldwide.
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
A study by scientists at the University of California, San Diego and UC Irvine has identified an enzyme called a proteasome phosphatase that appears to regulate removal of damaged proteins from a cell. The understanding of how this process works could have important implications for numerous diseases, including cancer and Parkinson's disease.
› Verified 9 days ago
Dr. Reshma Nair Haugen, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1600 N Randall Rd Ste 400, Elgin, IL 60123 Phone: 847-381-8899 Fax: 847-381-8999 | |
Tyler Conway, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1750 N Randall Rd Ste 120, Elgin, IL 60123 Phone: 847-608-6647 | |
Mr. Andrew J Thompson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1600 N Randall Rd, Suite 400, Elgin, IL 60123 Phone: 847-381-8899 | |
Dr. Jennifer R Hensley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1600 N Randall Rd, Suite 400, Elgin, IL 60123 Phone: 847-381-8899 Fax: 847-381-8999 | |
Dari Ann Ungaretti, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1710 N Randall Rd, Suite 380, Elgin, IL 60123 Phone: 847-742-1000 Fax: 847-742-1144 | |
Dr. Arsalan Qazi Shabbir, M.D., PH.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1750 N Randall Rd, Elgin, IL 60123 Phone: 847-608-6647 | |
Dr. Magdalena A. Kobierska, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1600 N Randall Rd Ste 400, Elgin, IL 60123 Phone: 847-381-8899 |